Hutch News

Hutch News

Stories tagged 'hiv vaccine trials network'

New 'mosaic' HIV vaccine study launched for World AIDS Day

As lights around the world glow red today, Fred Hutch-based researchers lead global effort to end the pandemic

Dec. 1, 2017 | By Mary Engel / Fred Hutch News Service

The HIV Vaccine Trials Network is having a banner year. Last month in South Africa, the network launched a clinical trial called the Imbokodo Study to test an experimental vaccine regimen designed to protect against HIV subtypes around the world. Over the coming months, the Imbokodo study will roll out in four other southern African countries.

View story >


Enlisting the microbiome in the quest for an AIDS vaccine

We now know that microbial communities, especially in our guts, profoundly affect immune response

Nov. 22, 2017 | By Sabin Russell / Fred Hutch News Service

Scientists at Fred Hutch are studying how the microbiome alters the immune system’s response to vaccines. Their work is already providing new insights on interactions between microbes in the body and the immune system that have implications for improving many types of vaccines.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 7, 2017

A common, normally dormant virus called cytomegalovirus can make matters worse for patients with critical illness — and a new study by Fred Hutch's Dr. Michael Boeckh and colleagues at the University of Washington hints that preventing the virus from reawakening in these critical moments could stem some of its harm.

View story >


Will the flu vaccine work for you? Answer may be in your genes

Set of 9 genes that predicts flu response in adults under 35 could be first step to personalized vaccine

Aug. 31, 2017 | By Rachel Tompa / Fred Hutch News Service

A newly uncovered set of genes that predicts whether the flu shot will work or not could be the first step toward a personalized flu vaccine.

View story >


Community-building leads to record enrollment in HIV prevention study

Fighting the stigma of HIV among communities of color takes trust — and time

Aug. 4, 2017 | By Mary Engel / Fred Hutch News Service

Vic Sorrell knows that the secret behind a successful HIV prevention study is spending the time to establish relationships and earn trust. A pioneer in community engagement, Sorrell works for the Vanderbilt HIV Vaccine Program, a unit of the Fred Hutch-based HIV Vaccine Trials Network.

View story >


Training tomorrow's HIV researchers

With no end yet to the pandemic, a program supports young South African physician-scientists

June 12, 2017 | By Mary Engel / Fred Hutch News Service

Dr. Nishila Moodley receives an award from her mentor, internationally acclaimed HIV researcher Dr. Glenda Gray, as the first graduate of the South African HVTN AIDS Vaccine Early Stage Investigator Programme.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.